ReleaseWire Connect

According to a new series of reports on the U.S. market for dental implant fixtures by iData Research (www.idataresearch.com), this market has yet to reach its potential as only a minority of those suffering tooth loss opt for a dental implant. However, the growing aging population as well as an increase in the number of professionals trained to place implants is set to drive this market. On the other hand, the growing popularity of value and discounted products has resulted in a shift of consumer preferences towards more inexpensive solutions. As a result, value and discount solutions have demonstrated success in gaining market share, and have consequently lowered the overall market's average selling price.

According to a new series of reports on the Europe market for laparoscopic devices by iData Research (www.idataresearch.com), the fastest growing market segment is the direct energy market driven by the popularity of advanced bipolar devices. As these devices become more common, electrosurgical generators will also grow as they are necessary for these products. However, the laparoscopic market is fairly mature, with many reusable products that do not need to be replaced too often. This is also the case for the hand instrument segment in Europe.

According to a new series of reports on the U.S. market for orthopedic small bone and joint devices by iData Research (http://www.idataresearch.com), growth in the market is led by the foot & ankle device and shoulder reconstruction device segments. The fastest growing segment is the foot & ankle market, which grew roughly 9% in 2016. The foot & ankle device market features by far the greatest number of procedures, but many of them use relatively inexpensive implants. There is a trend towards arthroplasty devices over arthrodesis, which carries a higher average selling price (ASP) such as with ankle replacement over fusion and the treatment of hammertoe with implants over K-wires. This shifts in product preference are propelling the foot & ankle market's growth due to the adoption of devices with higher ASPs.

According to a new series of reports on the Europe market for infusion therapy devices by iData Research (www.idataresearch.com), in this commoditized market, it is difficult for any one company to control the market completely. As a result, hospitals and large purchasing groups will make decisions based on the lowest price available. This is having a limiting effect on the Europe IV set market as it promotes pricing wars between competitors. However, as electronic medical records and smart pumps increase their penetration into the European market, the infusion pump market will be de-commoditized and the average selling price (ASP) is expected to be sustained for the next several years.

According to a new series of reports on the Europe market for orthopedic soft tissue repair by iData Research (http://www.idataresearch.com), all-suture anchors, also known as soft anchors, have been gaining market share in both the rotator cuff repair and shoulder labrum repair markets. As a result, many competitors have introduced their own all-suture anchor products. Growth is expected to continue over the next several years and will primarily be driven by increasing unit sales through technological innovation with the introduction of new products.

According to a new series of reports on the Europe market for orthopedic trauma devices by iData Research (http://www.idataresearch.com), the influx of new technology is driving the overall industry. For example, in the plate and screw market, growth is supported by the introduction of newer materials such as titanium and the development of locking/hybrid systems as well as the creation of anatomical plates. These higher cost devices are driving the market by replacing their legacy counterparts.

According to a new series of reports on the U.S. market for orthopedic biomaterials by iData Research (www.idataresearch.com), orthopedic growth factors have a relatively high average selling price (ASP) since their introduction to the market due to the high costs of recombinant growth factor technologies. The high research and development (R&D) costs associated with the growth factor segment provide a barrier to entry against potential competitors.

According to a new series of reports on the Europe market for minimally invasive surgery (MIS) spinal implants by iData Research (www.idataresearch.com), the strong growth rate of the market is expected to remain consistent as MIS segments are not yet reaching saturation. Most of the technologies in the overall market are relatively new, and saturation is limited by the need for clinical testing and the conservative nature of many European medical institutions, as well as by aspects like surgical complexity. In particular, percutaneous techniques and, to a lesser extent, retractor techniques are considered by many to be considerably more difficult to master than traditional open surgical methods. Older generations of doctors and surgeons are especially reluctant to switch to MIS, as it takes a considerable time investment to master the procedure.

According to a new series of reports on the U.S. market for spinal implants by iData Research (www.idataresearch.com), growth is largely driven by motion preservation devices, most notably artificial discs, as well as growth in the vertebral compression fracture market. Traditional fusion markets are expected to show strong rates of growth but will eventually begin to stabilize in value over the next several years as motion preservation and minimally invasive spinal procedures become increasingly common.

According to a new series of reports on the U.S. market for arthroscopic devices by iData Research (www.idataresearch.com), the transition to premium-priced bipolar radiofrequency (RF) probes will apply upward pressure to the value of the total RF probe market. However, the expiration of ArthroCare's COBLATION® patents has enabled Arthrex and ConMed Linvatec to launch new bipolar probes, causing substantial disruption in the high-value RF probe market. This increased competition in the bipolar RF probe segment is expected to drive modest price erosion, limiting growth. Firms launching new bipolar RF probes will seek to transition existing accounts from monopolar technology to their new bipolar RF probes. This effort is expected to cause unit sales of the monopolar segment to contract rapidly over the next several years.